Author Search Results

Joanne Berger-Sweeney

Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. Provided by Wikipedia

1

Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome

by Nupur Nag, Joanne E. Berger-Sweeney
Published 2007-05-01

Get full text

Article
2

Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.

by Laura R Schaevitz, Raffaella Nicolai, Carla M Lopez, Stefania D'Iddio, Emerenziana Iannoni, Joanne E Berger-Sweeney
Published 2012-01-01

Get full text

Article
3

Preclinical research in Rett syndrome: setting the foundation for translational success

by David M. Katz, Joanne E. Berger-Sweeney, James H. Eubanks, Monica J. Justice, Jeffrey L. Neul, Lucas Pozzo-Miller, Mary E. Blue, Diana Christian, Jacqueline N. Crawley, Maurizio Giustetto, Jacky Guy, C. James Howell, Miriam Kron, Sacha B. Nelson, Rodney C. Samaco, Laura R. Schaevitz, Coryse St. Hillaire-Clarke, Juan L. Young, Huda Y. Zoghbi, Laura A. Mamounas
Published 2012-11-01

Get full text

Article